Bausch Health puts Bausch + Lomb sale on ice
On February 6, Bausch Health Companies announced that it would continue to own 88% of Bausch + Lomb. Previously, Bausch Health’s management and Bausch + Lomb’s leadership had explored a potential sale after a private equity firm expressed interest in acquiring the eye health subsidiary at an attractive valuation. The process did not result in…